Your browser doesn't support javascript.
loading
Combination of early rhythm control and healthy lifestyle on the risk of stroke in elderly patients with new-onset atrial fibrillation: a nationwide population-based cohort study.
Lim, Woo-Hyun; Lee, So-Ryoung; Choi, Eue-Keun; Lee, Seung-Woo; Han, Kyung-Do; Oh, Seil; Lip, Gregory Y H.
Afiliación
  • Lim WH; Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul, Republic of Korea.
  • Lee SR; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Choi EK; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee SW; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Han KD; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Oh S; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Lip GYH; Department of Medical Statistics, College of Medicine, Catholic University of Korea, Seoul, Republic of Korea.
Front Cardiovasc Med ; 11: 1346414, 2024.
Article en En | MEDLINE | ID: mdl-38426116
ABSTRACT

Background:

The impact of early rhythm control (ERC) combined with healthy lifestyle (HLS) on the risk of ischemic stroke in elderly patients with atrial fibrillation (AF) remains unaddressed.

Objective:

To evaluate the impact of combined ERC and HLS on the risk of stroke in elderly patients with new-onset AF.

Methods:

Using the Korean National Health Insurance Service database, we included patients aged ≥75 years with new-onset AF from January 2009 to December 2016 (n = 41,315). Patients who received rhythm control therapy within 2 years of AF diagnosis were defined as the ERC group. Non-smoking, non-to-mild alcohol consumption (<105 g/week), and regular exercise were defined as HLS. Subjects were categorized into four groups group 1 (without ERC and HLS, n = 25,093), 2 (HLS alone, n = 8,351), 3 (ERC alone, n = 5,565), and 4 (both ERC and HLS, n = 2,306). We assessed the incidence of ischemic stroke as the primary outcome, along with admissions for heart failure, all-cause death, and the composite of ischemic stroke, admission for heart failure, and all-cause death.

Results:

Median follow-up duration of the study cohort was 3.4 years. After adjusting for multiple variables, groups 2 and 3 were associated with a lower stroke risk (adjusted hazard ratio [aHR] 95% confidence interval [CI] 0.867, 0.794-0.948 and 0.713, 0.637-0.798, respectively) than that of group 1. Compared to Group 1, group 4 showed the lowest stroke risk (aHR 0.694, 95% CI 0.586-0.822) among all groups, followed by group 3 (0.713, 0.637-0.798) and group 2 (0.857, 0.794-0.948), respectively. Group 4 was associated with the lowest risk of all-cause death (aHR 0.680, 95% CI 0.613-0.754) and the composite outcome (aHR 0.708, 95% CI 0.649-0.772).

Conclusion:

ERC and HLS were associated with a lower risk of ischemic stroke in elderly patients with new-onset AF. Concurrently implementing ERC and maintaining HLS was associated with the lowest risk of death and the composite outcome, with a modest synergistic effect on stroke prevention.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Front Cardiovasc Med Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: Front Cardiovasc Med Año: 2024 Tipo del documento: Article